SCHEMBL3471960

SCHEMBL3471960

COc1cc2c(OC)c(-c3c(C)cc4c(C(=O)NCc5c(C)cc(C)cc5C)c(OC)c(OC)cc4c3OC)c(C)cc2c(C(=O)NCc2c(C)cc(C)cc2C)c1OC

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCL2 P10415 1/20 0.55
BCL2L1 Q07817 1/20 0.55
MCL1 Q07820 1/20 0.55
LDHA P00338 1/20 0.38
NPC1 O15118 1/20 0.37
PDE3B Q13370 1/20 0.37
PDE3A Q14432 1/20 0.37
GABRA1 P14867 1/20 0.37
GABRG2 P18507 1/20 0.37
GABRB3 P28472 1/20 0.37
KMT2A Q03164 2/20 0.36
EZH2 Q15910 3/20 0.36
EED O75530 1/20 0.36
RBBP4 Q09028 1/20 0.36
SUZ12 Q15022 1/20 0.36
AEBP2 Q6ZN18 1/20 0.36
MEN1 O00255 1/20 0.35
ALDH1A1 P00352 1/20 0.35
KDM4E B2RXH2 1/20 0.35
POLB P06746 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3472763 0.76 TAAR1 (0.58) BCL2BCL2L1MCL1NPC1KMT2A
SCHEMBL3471236 0.76 MAPT (0.51) BCL2BCL2L1MCL1NPC1KMT2A
SCHEMBL353909 0.76 MEN1 (0.43) LDHAKMT2AMEN1ALDH1A1KDM4E
SCHEMBL3265536 0.75 BCL2 (0.59) BCL2BCL2L1MCL1NPC1ALDH1A1
SCHEMBL3471000 0.75 BCL2 (0.59) BCL2BCL2L1MCL1NPC1ALDH1A1
SCHEMBL3474066 0.74 KMT2A (0.52) MCL1KMT2AMEN1ALDH1A1KDM4E
SCHEMBL2757193 0.71 MEN1 (0.43) LDHAKMT2AMEN1ALDH1A1KDM4E
SCHEMBL635910 0.71 BCL2L1 (1.00) BCL2BCL2L1MCL1
SCHEMBL353111 0.70 TACR3 (0.54) KMT2AMEN1ALDH1A1KDM4ELMNA
SCHEMBL15107497 0.70 BCL2 (0.56) BCL2BCL2L1MCL1NPC1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2418942-B1 NAPHTHALENE-BASED INHIBITORS OF ANTI-APOPTOTIC PROTEINS SANFORD-BURNHAM MEDICAL RES INST (US) 2017-08-23 EP disclosed
US-8436207-B2 Naphthalene-based inhibitors of anti-apoptotic proteins BURNHAM INSTITUTE FOR MEDICAL RESEARCH (US) 2013-05-07 US disclosed
US-20100267781-A1 NAPHTHALENE-BASED INHIBITORS OF ANTI-APOPTOTIC PROTEINS BURNHAM INSTITUTE FOR MEDICAL RESEARCH (US) 2010-10-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100267781-A1 NAPHTHALENE-BASED INHIBITORS OF ANTI-APOPTOTIC PROTEINS HAX1, BAX, APOL1 BCL2 11/4885BCL2L1 20/4885MCL1 233/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.